<VariationArchive RecordType="classified" VariationID="691324" VariationName="NM_000088.4(COL1A1):c.1492del (p.Ala498fs)" VariationType="Deletion" Accession="VCV000691324" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-06-05" DateCreated="2020-01-13" MostRecentSubmission="2020-01-13">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="679018" VariationID="691324">
      <GeneList>
        <Gene Symbol="COL1A1" FullName="collagen type I alpha 1 chain" GeneID="1277" HGNC_ID="HGNC:2197" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17q21.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="50184101" stop="50201631" display_start="50184101" display_stop="50201631" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="48261456" stop="48278999" display_start="48261456" display_stop="48278999" Strand="-" />
          </Location>
          <OMIM>120150</OMIM>
          <Haploinsufficiency last_evaluated="2012-08-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=COL1A1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-08-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=COL1A1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000088.4(COL1A1):c.1492del (p.Ala498fs)</Name>
      <CanonicalSPDI>NC_000017.11:50194595:C:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17q21.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="50194596" stop="50194596" display_start="50194596" display_stop="50194596" variantLength="1" positionVCF="50194595" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="48271957" stop="48271957" display_start="48271957" display_stop="48271957" variantLength="1" positionVCF="48271956" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>A498fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.48271957del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.48271957del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.50194596del" Assembly="GRCh38">
            <Expression>NC_000017.11:g.50194596del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007400.1" sequenceAccession="NG_007400" sequenceVersion="1" change="g.12044del">
            <Expression>NG_007400.1:g.12044del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000088.4" sequenceAccession="NM_000088" sequenceVersion="4" change="c.1492del" MANESelect="true">
            <Expression>NM_000088.4:c.1492del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000079.2" sequenceAccession="NP_000079" sequenceVersion="2" change="p.Ala498fs">
            <Expression>NP_000079.2:p.Ala498fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1" sequenceAccession="LRG_1">
            <Expression>LRG_1:g.12044del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000088.3" sequenceAccession="NM_000088" sequenceVersion="3" change="c.1492delG">
            <Expression>NM_000088.3:c.1492delG</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1598295794" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000088.4(COL1A1):c.1492del (p.Ala498fs) AND Osteogenesis imperfecta" Accession="RCV000991253" Version="2">
        <ClassifiedConditionList TraitSetID="5689">
          <ClassifiedCondition DB="MedGen" ID="C0029434">Osteogenesis imperfecta</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-07-11" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-07-11" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-01-13" MostRecentSubmission="2020-01-13">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="5689" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6312" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Osteogenesis imperfecta</ElementValue>
                <XRef ID="Osteogenesis+imperfecta/5451" DB="Genetic Alliance" />
                <XRef ID="MONDO:0019019" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS166200" DB="OMIM" />
                <XRef ID="78314001" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">OI</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1017" />
                <XRef ID="1017" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">COL1A1/2 osteogenesis imperfecta (COL1A1/2-OI) is characterized by fractures with minimal or absent trauma, variable dentinogenesis imperfecta (DI), and, in adult years, hearing loss. The clinical features of COL1A1/2-OI represent a continuum ranging from perinatal lethality to individuals with severe skeletal deformities, mobility impairments, and very short stature to nearly asymptomatic individuals with a mild predisposition to fractures, normal dentition, normal stature, and normal life span. Fractures can occur in any bone but are most common in the extremities. DI is characterized by gray or brown teeth that may appear translucent, wear down, and break easily. COL1A1/2-OI has been classified into four types based on clinical presentation and radiographic findings. This classification system can be helpful in providing information about prognosis and management for a given individual. The four more common OI types are now referred to as follows: Classic non-deforming OI with blue sclerae (previously OI type I). Perinatally lethal OI (previously OI type II). Progressively deforming OI (previously OI type III). Common variable OI with normal sclerae (previously OI type IV).</Attribute>
                <XRef ID="NBK1295" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301472</ID>
                <ID Source="BookShelf">NBK1295</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG, 2006">
                <ID Source="pmc">3110960</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG, 2008">
                <ID Source="pmc">3111019</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="EMQN, 2012">
                <ID Source="pmc">3234509</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2008">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_OsteogenesisImperfecta.pdf</URL>
                <CitationText>Orphanet Emergency Guidelines: Osteogenesis imperfecta (OI)</CitationText>
              </Citation>
              <XRef ID="666" DB="Orphanet" />
              <XRef ID="C0029434" DB="MedGen" />
              <XRef ID="D010013" DB="MeSH" />
              <XRef ID="MONDO:0019019" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS166200" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1949416" SubmissionDate="2019-07-12" DateLastUpdated="2020-01-13" DateCreated="2020-01-13">
        <ClinVarSubmissionID localKey="NM_000088.3:c.1492delG|Orphanet:666" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000994668" DateUpdated="2020-01-13" DateCreated="2020-01-13" Type="SCV" Version="1" SubmitterName="Genetics Department, Polish Mother's Memorial Hospital Research Institute" OrgID="507063" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-07-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>paternal</Origin>
              <Ethnicity>European, Polish</Ethnicity>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL1A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000088.3:c.1492delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA666" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5947767</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1949416" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA666" MappingRef="Orphanet">
        <MedGen CUI="C0029434" Name="Osteogenesis imperfecta" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

